Home > Name List By other > (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3, 3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quino... India

CAS No 98319-26-7 , (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,
3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide Search by region : India

  • Name: (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,
    3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
  • Synonyms: Prostide; Finastid; MK-906; Chibro-Proscar; Finasterida;(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,
    3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide; Propecia; 98319-26-7; Finpecia;Proscar;
  • CAS Registry Number:
  • Transport: 25kgs
  • Density: 1.065 g/cm3
  • Refractive index: 1.524
  • Safety Statements: R22;R60;R61
  • Hazard Symbols: T: Toxic;
  • Molecular Weight: 372.54414
  • InchiKey: DBEPLOCGEIEOCV-WSBQPABSSA-N
  • InChI: InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,
    13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,
    24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1
  • Risk Statements: S36/37/39;S45;S53
  • Molecular Formula: C23H36N2O2
  • Molecular Structure:CAS No:98319-26-7 (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,<br />3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide

Related products

Select to

98319-26-7 Finasteride

  • IUPAC NAME-N-(1,1-dimethylethyl)-3-oxo- (5α,17β)-4-azaandrost-1-ene-17-carboxamide MOLECULAR FORMULA-C23H36N2O2 MOLAR MASS-372.549 g/mol Physicians use finasteride for the treatment of benign prostatic hyperplasia informally known as an enlarged pr...
  • India Swapnroop Drugs & Pharmaceuticals [Manufacturer, Trading Company, Distributor/Wholesaler]
  • Tel: 91-240-6641875
  • Fax: 91-240-6641870
  • Address: Plot No: 04, Mayur Park, Harsool Aurangabad,MaharashtraIndia
Contact Supplier

98319-26-7 FINASTERIDE

  • India JAI RADHE SALES null
  • Fax: 0091-79-26569884
  • Address: 309/310 HARIKRUPA TOWER,NR.OLD SHARDA MANDIR CHAR RASTA,ELLISBRIDGE ,AHMEDABAD,GUJRAT , INDIA. null,nullIndia
Contact Supplier

98319-26-7 Finasteride

  • India Shreeji Pharma International [Manufacturers]
  • Tel: +91-265-3019110
  • Fax: +91-265-2465036
  • Address: FF/10, Narsinghdham Complex, Sangam Chararasta, Harni Road, Vadodara, Gujarat 390018, Vadodara,GujaratIndia
Contact Supplier

98319-26-7 Finasteride

  • Finasteride, IHS; (GMP of SFDA)
  • India J.INC. [Manufacturer]
  • Tel: +91 79 30071152, 30071190, 30071175, 30071153
  • Fax: +91 79 30071176, 26574630
  • Address: # 95, Rangwala Towers, Law garden, Ellisbridge, Ahmedabad 380006, Gujarat State, India. 380006 AhmedabadINDIA Ahmedabad,nullIndia
Contact Supplier

98319-26-7 Finasteride

  • India Exim-Pharm International null
  • Tel: +91-(22)-26191948
  • Fax: +91-(22)-26191948
  • Address: 1, Ashish Mahal, 2nd Floor, Ist Road, Golibar Santacruz (E), Mumbai, Maharashtra 400 055, null,nullIndia
Contact Supplier

Select to

1/1
References of (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,
3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
Title: Finasteride
CAS Registry Number: 98319-26-7
CAS Name: (5a,17b)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
Synonyms: 17b-(N-tert-butylcarbamoyl)-4-aza-5a-androst-1-en-3-one
Manufacturers' Codes: MK-906
Trademarks: Chibro-Proscar (Chibret); Finastid (Neopharmed); Propecia (Merck & Co.); Proscar (Merck & Co.); Prostide (Sigma-Tau)
Molecular Formula: C23H36N2O2
Molecular Weight: 372.54
Percent Composition: C 74.15%, H 9.74%, N 7.52%, O 8.59%
Literature References: Inhibitor of 5a-reductase, the enzyme which converts testosterone to the more potent androgen, 5a-dihydrotestosterone. Prepn: G. H. Rasmusson, G. F. Reynolds, EP 155096; eidem, US 4760071 (1985, 1988 both to Merck & Co.); G. H. Rasmusson et al., J. Med. Chem. 29, 2298 (1986); A. Bhattacharya et al., J. Am. Chem. Soc. 110, 3318 (1988). HPLC determn in plasma and urine: J. R. Carlin et al., J. Chromatogr. 427, 79 (1988). Review of pharmacology and clinical uses: S. L. Sudduth, M. J. Koronkowski, Pharmacotherapy 13, 309-329 (1993). Clinical trials in benign prostatic hyperplasia: J. L. Tenover et al., Clin. Ther. 19, 243 (1997); J. D. McConnell et al., N. Engl. J. Med. 338, 557 (1998); in male pattern hair loss: K. D. Kaufman et al., J. Am. Acad. Dermatol. 39, 578 (1998).
Properties: White to off-white crystalline solid, mp ~257° (dried to anhydrous under N2). Also reported as mp 252-254° (Rasmusson, 1988). [a]405 -59° (c = 1 in methanol). Freely sol in chloroform, DMSO, ethanol, methanol, n-propanol; sparingly sol in propylene glycol, polyethylene glycol 400; very slightly sol in 0.1N HCl, 0.1N NaOH, water.
Melting point: mp ~257° (dried to anhydrous under N2); mp 252-254° (Rasmusson, 1988)
Optical Rotation: [a]405 -59° (c = 1 in methanol)
Therap-Cat: Treatment of benign prostatic hypertrophy. Antialopecia agent.
Keywords: Antialopecia Agent; Antiprostatic Hypertrophy; 5a-Reductase Inhibitor.